India to Australia: Exemestane Export Trade Route

The India to Australia Exemestane corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $224.2K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's exemestane manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $17.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with exemestane's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 17.0%, placing it at rank #14 among India's top exemestane export destinations globally.

On the import side, key buyers of Indian exemestane in Australia include GENERIC HEALTH PTY LTD , GENERIC HEALTH PTY LIMITED, TO THE ORDER and 8 others. GENERIC HEALTH PTY LTD is the single largest importer with 1 shipments valued at $77.2K USD.

India's exemestane exports to Australia are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , MAXWELL ENTERPRISES — together account for 100% of total trade value on this route. The average shipment value of $17.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs and medi exemestane-gh 25mg2x15t as per invnos and pharma drugs and medi exemestane gh 25mg2x15t as per inv, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, GENERIC HEALTH PTY LTD is the largest importer with 1 shipments worth $77.2K USD — representing 34% of all exemestane imports from India on this route. A total of 11 buyers are active on this corridor.